# Inhibition of MMP-9 Activity Impairs Working Memory in Zebrafish Through Changes in Overall Hippocampal Excitation

> **NIH NIH K00** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2024 · $87,134

## Abstract

ABSTRACT
Over 300 million people worldwide suffer from Major Depressive Disorder (MDD), a heterogenous disorder with
no cure. MDD is associated with hippocampal-dependent memory impairments, including severe working
memory (WM) deficits. The encoding and consolidation of newly acquired experiences rely on the finely tuned
interplay between pyramidal excitatory neurons and GABAergic parvalbumin positive (PV) interneurons that
control the excitation to inhibition (E/I) balance in the hippocampus. The interplay between these two neuronal
populations in the hippocampus results in the temporally coordinated firing of pyramidal neurons that give rise
to theta/gamma oscillations and sharp wave ripple (SWR) events, underlying the proper encoding and
consolidation of information, respectively.
 In patients suffering from MDD both encoding and consolidation of experiences are impaired due to a shift
in their hippocampal E/I balance to a less excitatory state. Strikingly, our lab has shown that the antidepressant
venlafaxine rescues WM in a stress mouse model through increasing gamma oscillations and SWR abundance
in the hippocampus. This increase was dependent on Matrix Metalloproteinase-9 (MMP-9), a gelatinase that
remodels the extracellular matrix and is altered in MDD. Following in this line of research, my dissertation focuses
on the role of MMP-9 activity in the proper functioning of hippocampal-dependent neuronal networks in the
zebrafish. My behavioral data indicates that MMP-9 inhibition impairs WM, which was accompanied by changes
in the E/I balance in the hippocampus to a less excitatory state as evidenced by a decrease in SWR abundance.
Additionally, my proteomics data suggest that the shift in E/I balance can be explained by changes in both
pyramidal and PV neurons. For instance, plasminogen, a marker for excitatory neuronal activity was significantly
decreased after MMP-9 inhibition. Components of the Perineuronal Nets (PNN), that regulate the firing of PV
neurons, such as versican, were significantly increased. These changes contribute to a less excitatory
hippocampus similar to what we see in patients suffering from MDD. My data then postulates MMP-9 activity
modulation as a potential therapeutic target to treating depression-related symptoms.
 For the D-SPAN F99/K00 training grant, I have two specific aims. For Aim 1 (F99 phase) I have outlined
my progress thus far and how I will master whole-cell patch clamp and optical sensing recordings to distinguish
how MMP-9 inhibition differentially affects the intrinsic properties of pyramidal and PV neurons and whether
theta/gamma oscillations are also affected. After successfully graduating, for the K00 phase I will join my ideal
postdoctoral lab at an R1 institution dedicated to scientific excellence, professional and intellectual development,
networking, and increasing and retaining diverse scientists in academia. I will also continue studying the cellular
and molecular mechanisms leading to neu...

## Key facts

- **NIH application ID:** 10794916
- **Project number:** 4K00NS130872-02
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Ismary Blanco
- **Activity code:** K00 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $87,134
- **Award type:** 4N
- **Project period:** 2022-09-15 → 2028-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10794916

## Citation

> US National Institutes of Health, RePORTER application 10794916, Inhibition of MMP-9 Activity Impairs Working Memory in Zebrafish Through Changes in Overall Hippocampal Excitation (4K00NS130872-02). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10794916. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
